These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

519 related items for PubMed ID: 16288376

  • 1. Impact of immunization with glycoprotein D2/AS04 on herpes simplex virus type 2 shedding into the genital tract in guinea pigs that become infected.
    Bourne N, Milligan GN, Stanberry LR, Stegall R, Pyles RB.
    J Infect Dis; 2005 Dec 15; 192(12):2117-23. PubMed ID: 16288376
    [Abstract] [Full Text] [Related]

  • 2. Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs.
    Bourne N, Bravo FJ, Francotte M, Bernstein DI, Myers MG, Slaoui M, Stanberry LR.
    J Infect Dis; 2003 Feb 15; 187(4):542-9. PubMed ID: 12599070
    [Abstract] [Full Text] [Related]

  • 3. Effect of immunization with herpes simplex virus type-1 (HSV-1) glycoprotein D (gD) plus the immune enhancer GPI-0100 on infection with HSV-1 or HSV-2.
    Quenelle DC, Collins DJ, Marciani DJ, Kern ER.
    Vaccine; 2006 Mar 06; 24(10):1515-22. PubMed ID: 16288820
    [Abstract] [Full Text] [Related]

  • 4. Immunogenicity, protective efficacy, and non-replicative status of the HSV-2 vaccine candidate HSV529 in mice and guinea pigs.
    Bernard MC, Barban V, Pradezynski F, de Montfort A, Ryall R, Caillet C, Londono-Hayes P.
    PLoS One; 2015 Mar 06; 10(4):e0121518. PubMed ID: 25837802
    [Abstract] [Full Text] [Related]

  • 5. Enhancement of protective humoral immune responses against Herpes simplex virus-2 in DNA-immunized guinea-pigs using protein boosting.
    Fotouhi F, Soleimanjahi H, Roostaee MH, Behzadian F.
    FEMS Immunol Med Microbiol; 2008 Oct 06; 54(1):18-26. PubMed ID: 18647350
    [Abstract] [Full Text] [Related]

  • 6. Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor 88.
    Tengvall S, O'Hagan D, Harandi AM.
    Antiviral Res; 2008 Jun 06; 78(3):202-14. PubMed ID: 18276020
    [Abstract] [Full Text] [Related]

  • 7. A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens.
    Awasthi S, Mahairas GG, Shaw CE, Huang ML, Koelle DM, Posavad C, Corey L, Friedman HM.
    J Virol; 2015 Aug 06; 89(16):8497-509. PubMed ID: 26041292
    [Abstract] [Full Text] [Related]

  • 8. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
    Da Costa XJ, Morrison LA, Knipe DM.
    Virology; 2001 Sep 30; 288(2):256-63. PubMed ID: 11601897
    [Abstract] [Full Text] [Related]

  • 9. Effects of herpes simplex virus type 2 glycoprotein vaccines and CLDC adjuvant on genital herpes infection in the guinea pig.
    Bernstein DI, Earwood JD, Bravo FJ, Cohen GH, Eisenberg RJ, Clark JR, Fairman J, Cardin RD.
    Vaccine; 2011 Mar 03; 29(11):2071-8. PubMed ID: 21238569
    [Abstract] [Full Text] [Related]

  • 10. The HSV-1 live attenuated VC2 vaccine provides protection against HSV-2 genital infection in the guinea pig model of genital herpes.
    Bernstein DI, Pullum DA, Cardin RD, Bravo FJ, Dixon DA, Kousoulas KG.
    Vaccine; 2019 Jan 03; 37(1):61-68. PubMed ID: 30471955
    [Abstract] [Full Text] [Related]

  • 11. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons.
    Wald A, Zeh J, Selke S, Warren T, Ryncarz AJ, Ashley R, Krieger JN, Corey L.
    N Engl J Med; 2000 Mar 23; 342(12):844-50. PubMed ID: 10727588
    [Abstract] [Full Text] [Related]

  • 12. A vaccine containing highly purified virus particles in adjuvant provides high level protection against genital infection and disease in guinea pigs challenged intravaginally with homologous and heterologous strains of herpes simplex virus type 2.
    Bernstein DI, Morello CS, Cardin RD, Bravo FJ, Kraynyak KA, Spector DH.
    Vaccine; 2020 Jan 03; 38(1):79-89. PubMed ID: 31611098
    [Abstract] [Full Text] [Related]

  • 13. The adjuvant CLDC increases protection of a herpes simplex type 2 glycoprotein D vaccine in guinea pigs.
    Bernstein DI, Farley N, Bravo FJ, Earwood J, McNeal M, Fairman J, Cardin R.
    Vaccine; 2010 May 07; 28(21):3748-53. PubMed ID: 19857450
    [Abstract] [Full Text] [Related]

  • 14. Nasal and skin delivery of IC31(®)-adjuvanted recombinant HSV-2 gD protein confers protection against genital herpes.
    Wizel B, Persson J, Thörn K, Nagy E, Harandi AM.
    Vaccine; 2012 Jun 19; 30(29):4361-8. PubMed ID: 22682292
    [Abstract] [Full Text] [Related]

  • 15. Comparative efficacy and immunogenicity of replication-defective, recombinant glycoprotein, and DNA vaccines for herpes simplex virus 2 infections in mice and guinea pigs.
    Hoshino Y, Dalai SK, Wang K, Pesnicak L, Lau TY, Knipe DM, Cohen JI, Straus SE.
    J Virol; 2005 Jan 19; 79(1):410-8. PubMed ID: 15596834
    [Abstract] [Full Text] [Related]

  • 16. Protection from herpes simplex virus (HSV)-2 infection with replication-defective HSV-2 or glycoprotein D2 vaccines in HSV-1-seropositive and HSV-1-seronegative guinea pigs.
    Hoshino Y, Pesnicak L, Dowdell KC, Burbelo PD, Knipe DM, Straus SE, Cohen JI.
    J Infect Dis; 2009 Oct 01; 200(7):1088-95. PubMed ID: 19702506
    [Abstract] [Full Text] [Related]

  • 17. Expression of the herpes simplex virus type 2 glycoprotein D in baculovirus expression system and evaluation of its immunogenicity in guinea pigs.
    Fotouhi F, Soleimanjahi H, Roostaee MH, Dalimi Asl A.
    Iran Biomed J; 2008 Apr 01; 12(2):59-66. PubMed ID: 18506211
    [Abstract] [Full Text] [Related]

  • 18. Construction and characterization of a replication-defective herpes simplex virus 2 ICP8 mutant strain and its use in immunization studies in a guinea pig model of genital disease.
    Da Costa XJ, Bourne N, Stanberry LR, Knipe DM.
    Virology; 1997 May 26; 232(1):1-12. PubMed ID: 9185583
    [Abstract] [Full Text] [Related]

  • 19. Genital shedding of herpes simplex virus among men.
    Wald A, Zeh J, Selke S, Warren T, Ashley R, Corey L.
    J Infect Dis; 2002 Oct 15; 186 Suppl 1():S34-9. PubMed ID: 12353185
    [Abstract] [Full Text] [Related]

  • 20. Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model.
    Manservigi R, Boero A, Argnani R, Caselli E, Zucchini S, Miriagou V, Mavromara P, Cilli M, Grossi MP, Balboni PG, Cassai E.
    Vaccine; 2005 Jan 04; 23(7):865-72. PubMed ID: 15603886
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.